Depressant effects of ambroxol on lipopolysaccharide- or fMLP-stimulated free radical production and granule enzyme release by alveolar macrophages

Pulmonary Pharmacology and Therapeutics

Volumn 12, Issue 5, 1999, Pages 275-284

  Lee, C S ^a   Jang, Y Y ^a   Han, E S ^a  

^a Chung Ang University   (South Korea)

Author keywords

Alveolar macrophages; Ambroxol; fMLP; Functional responses; LPS

Indexed keywords

ACID PHOSPHATASE; AMBROXOL; CALCIUM ION; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FREE RADICAL; GENISTEIN; LIPOPOLYSACCHARIDE; LYSOZYME; N,N DIMETHYLSPHINGOSINE; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; STAUROSPORINE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME RELEASE; GRANULE CELL; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032700970     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1999.0214     Document Type: Article

References (59)

1. Morrison D C, Ryan J L. Bacterial endotoxins and host immune responses. Adv Immunol. 28:1979;293-299.
2. Yoo H S, Maheswaran S K, Lin G, Townsend E L, Ames T R. Induction of inflammatory cytokines in bovine alveolar macrophages following stimulation with Pasteurella haemolytica lipopolysaccharide. Infect Immun. 63:1995;381-388.
3. Fidler I J, Schroit A J. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta. 948:1988;151-173.
4. Fidler I J. Macrophages and metastasis - a biological approach to cancer therapy. Cancer Res. 45:1985;4714-4726.
5. Nathan C F. Secretory products of macrophages. J Clin Invest. 79:1987;319-326.
6. Kadri C, Cherqui G, Masliah J, Rybkine E, Bereziat G. Mechanism of N-formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-induced arachidonic acid release in guinea pig alveolar macrophages: involvement of a GTP-binding protein and role of protein kinase A and protein kinase C. Mol Pharmacol. 38:1990;418-425.
7. Abu-Lawi K I, Sultzer B M. The tyrosine phosphorylation of a p72syk-like protein in activated murine resident peritoneal macrophages. Cell Mol Biol Res. 41:1995;49-58.
8. Surette M E, Palmantier R, Gosselin J, Borgeat P. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen. J Exp Med. 178:1993;1347-1355.
9. Leeson M C, Fujihara Y, Morrison D C. Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infect Immun. 62:1994;4975-4980.
10. Chen Y Q, Fisher J H, Wang M H. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J Immunol. 161:1998;4950-4959.
11. Lockhart B P, Cressey K C, Lepagnol J M. Suppression of nitric oxide formation by tyrosine kinase inhibitors in murine N9 microglia. Br J Pharmacol. 123:1998;879-889.
12. St-Denis A, Chano F, Tremblay P, St-Pierre Y, Descoteaux A. Protein kinase C-alpha modulates lipopolysaccharide-induced functions in a murine macrophage cell line. J Biol Chem. 273:1998;32787-32792.
13. Lackie J M. Aspects of the behaviour of neutrophil leukocytes. In: Bellaris R, Curtis A, Dunn G, eds. Cell behaviour. Cambridge: Cambridge University Press. 1982;319-348.
14. Becker E L. The formylpeptide receptor of the neutrophil. A search and conserve operation. Am J Pathol. 129:1987;16-24.
15. Disse B G. The pharmacology of ambroxol. Eur J Respir Dis. 153:1987;255-262.
16. Wauer R R, Schmalisch G, Bohme B, Arand J, Lehmann D. Randomized double blind trial of ambroxol for the treatment of respiratory distress syndrome. Eur J Pediatr. 151:1992;357-363.
17. Fegiz G. Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind italian multicenter clinical study versus placebo. Lung. 169:1991;69-76.
18. Stockley R A, Shaw J, Burnett D. Effect of ambroxol on neutrophil chemotaxis in vitro. Agents and Actions. 24:1988;292-296.
19. Bianchi M, Mantovani E, Erroi A, Dinarello C A, Ghezzi P. Ambroxol inhibits interleukin 1 and tumor necrosis factor production in human mononuclear cells. Agents and Actions. 31:1990;275-279.
20. Pfeifer S, Zissel G, Kienast K, Muller- Quernheim J. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. Eur J Med Res. 24:1997;129-132.
21. 2+change in degraded immunoglibulin G-activated neutrophils. Pharmacol Toxicol. 84:1999;81-89.
22. Suzuki M, Teramoto S, Matsuse T, Ohga E, Katayama H, Fukuchi Y, Ouchi Y. Inhibitory effect of ambroxol on superoxide anion production and generation by murine lung alveolar macrophages. J Asthma. 35:1998;267-272.
23. Nowak D, Antczak A, Pietras T, Bialasiewicz P, Krol M. Protective effect of ambroxol against heat- and hydrogen peroxide- induced damage to lung lipids in mice. Eur Resp J. 7:1994;1629-1634.
24. Koh J Y, Han E S, Lee C S. Protective action of ambroxol on the oxidative damages of lipid, hyaluronic acid and collagen. J Appl Pharmacol. 6:1998;111-118.
25. Nemery B, Vanlommel S, Verbeken E K, Laumeryns J M, Demedts M. Lung injury induced by paraquat, hyperoxia and cobalt chloride: effects of ambroxol. Pulm Pharmacol. 5:1992;53-60.
26. Piotrowski W J, Pietras T, Kurmanowska Z, Nowak D, Marczak J, Marks-Konczalik J, Mazerant P. Effect of paraquat intoxication and ambroxol treatment on hydrogen peroxide production and lipid peroxidation in selected organs of rat. J Appl Toxicol. 16:1996;501-507.
27. Witz G, Lawrie N J, Amoruso M A, Goldstein B D. Inhibition by reactive aldehydes of superoxide anion radical production from stimulated polymorphonuclear leukocytes and pulmonary alveolar macrophages. Effects on cellular sulfhydryl groups and NADPH oxidase activity. Biochem Pharmacol. 36:1987;721-726.
28. -production by human neutrophils, the preparation and assay of NADPH oxidase-containing particles from human neutrophilA. In: Packer L, ed. Methods in Enzymology. London: Academic Press, 105:1984;358-365.
29. Pick E, Mizell D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic immunoassay reader. J Immunol Meth. 46:1981;211-226.
30. Gilad E, Wong H R, Zingarelli B, Virag L, O'Connor M, Salzman A L, Szaba C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation. FASEB J. 12:1998;685-693.
31. Bertholet S, Tzeng E, Felley-Bosco E, Mauel J. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leuk Biol. 65:1999;50-58.
32. Stuehr D J, Fasehun O A, Kwon N S, Gross S S, Gonzalez J A, Levi R, Nathan C F. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5:1991;98-103.
33. Burt H M, Jackson J K, Salari H. Inhibition of crystal- induced neutrophil activation by a protein tyrosine kinase inhibitor. J Leuk Biol. 55:1994;112-119.
34. 2+mobilization with leukotriene A4 and epoxytetraenes in human neutrophils. Biochem Pharmacol. 39:1990;355-365.
35. Pahan K, Sheikh F G, Namboodiri A M, Singh I. N-acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Rad Biol Med. 24:1998;39-48.
36. Han C H, Yoon Y C, Shin Y K, Han E S, Lee C S. Comparision of regulatory action of cAMP and cGMP on the activation of neutrophil responses. Kor J Physiol Pharmacol. 1:1997;97-105.
37. Tauber A I. Protein kinase C and the activation of the human neutrophil NADPH-oxidase. Blood. 69:1987;711-720.
38. Igarashi Y, Hakomori S, Toyokuni T, Dean B, Fujita S, Sugimoto M, Ogawa T, el-Ghendy K, Racker E. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry. 22:1989;6796-6800.
39. Igarashi Y, Kitamura K, Toyokuni T, Dean B, Fenderson B, Ogawa T, Hakomori S. A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation. Demonstration of its endogenous occurrence (and the virtual absence of unsubstituted sphingosine) in human epidermoid carcinoma A431 cells. J Biol Chem. 265:1990;5385-5389.
40. Weiss S J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-376.
41. Cochrane C G, Spragg R, Revak S. Pathogenesis of the adult respiratory distress syndrome. J Clin Invest. 71:1983;754-761.
42. Sommerhoff C P, Nadel J A, Basbaum C B, Caughey G H. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest. 85:1990;682-689.
43. Nowak D, Antczak A, Krol M, Bialasiewicz P, Pietras T. Antioxidant properties of ambroxol. Free Rad Biol Med. 16:1994;517-522.
44. Teramoto S, Suzuki M, Matsuse T, Ouchi Y. Effect of ambroxol on oxygen radical production and generation by bronchoalveolar lavage cells in young and aged guinea pigs. Jpn J Pharmacol. 78:1998;429-434.
45. Sedgwick A D, Dawson J, Lees P. Influence of chemotactic agents on the locomotion of equine polymorphonuclear and mononuclear leucocytes. Res Vet Sci. 43:1987;55-58.
46. Bokoch G M. Chemoattractant signaling and leukocyte activation. Blood. 86:1995;1649-1660.
47. Takemura O S, Banno Y, Nozawa Y. Inhibition of N-formylmethionyl-leucyl-phenylalanine-stimulated tyrosine phosphorylation and phospholipase D activation by quercetin in rabbit neutrophils. Biochem Pharmacol. 53:1997;1503-1510.
48. Gillissen A, Bartling A, Schoen S, Schultze-Werninghaus G. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung. 175:1997;235-242.
49. Gillissen A, Scharling B, Jaworska M, Bartling A, Rasche K, Schultze-Werninghaus G. Oxidant scavenger function of ambroxol in vitro: a comparison with N-acetylcysteine. Res Exp Med. 196:1997;389-398.
50. Ahn S K, Shin Y K, Kang H J, Han E S, Lee C S. Effects of protein kinase inhibitors on the stimulated neutrophil responses by degraded immunoglobulin G. Eur J Pharmacol. 306:1996;175-180.
51. Kimura S, Kawa S, Ruan F, Nisar M, Sadahira Y, Hakomori S, Igarashi Y. Effect of sphingosine and its N-methyl derivatives on oxidative burst, phagokinetic activity, and trans-endothelial migration of human neutrophils. Biochem Pharmacol. 44:1992;1585-1595.
52. Alemany R, Meyer zu Heringdorf D, van Koppen C J, Jakobs K H. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J Biol Chem. 274:1999;3994-3999.
53. Waga I, Nakamura M, Honda Z, Ferby I, Toyoshima S, Ishiguro S, Shimizu T. Two distinct signal transduction pathways for the activation of guinea-pig macrophages and neutrophils by endotoxin. Biochem Biophys Res Commun. 197:1993;465-472.
54. Westwick J, Poll C. Mechanisms of calcium homeostasis in the polymorphonuclear leukocytes. Agents and Actions. 19:1986;80-86.
55. Cobbold P H, Rink T J. Fluorescence and bioluminescence measurement of cytoplasmic free calcium. Biochem J. 248:1987;313-328.
56. Berridge M J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Ann Rev Bichem. 56:1987;159-193.
57. Randriamampita C, Trautmann A. Biphasic increase in intracellular calcium induced by platelet-activating factor in macrophages. FEBS Letts. 249:1989;199-206.
58. Lee C S, Kim Y J, Shin Y K, Lee K S. Role of calcium and protein kinase C in platelet activating factor-induced activation of peritoneal macrophages. Kor J Pharmacol. 29:1993;107-120.
59. 2+entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2, 5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem. 268:1993;18151-18156.